Cheah I, Hunter J, Gelissen I, Chan W, Harnett J
Support Care Cancer. 2024; 33(1):40.
PMID: 39694905
PMC: 11655613.
DOI: 10.1007/s00520-024-09087-w.
Datta I, Erridge S, Holvey C, Coomber R, Guru R, Holden W
Pain Pract. 2024; 25(1):e13438.
PMID: 39545361
PMC: 11683519.
DOI: 10.1111/papr.13438.
Gibson L, Ferrer R, Meghani S, Acevedo A
J Natl Cancer Inst. 2024; 116(7):1019-1025.
PMID: 38471103
PMC: 11223862.
DOI: 10.1093/jnci/djae058.
Zeng F, Wade A, Harbert K, Patel S, Holley J, Dehghanpuor C
Sci Rep. 2024; 14(1):5782.
PMID: 38461339
PMC: 10924854.
DOI: 10.1038/s41598-024-56220-0.
Hauser W, Welsch P, Radbruch L, Fisher E, Bell R, Moore R
Cochrane Database Syst Rev. 2023; 6:CD014915.
PMID: 37283486
PMC: 10241005.
DOI: 10.1002/14651858.CD014915.pub2.
Cannabinoids versus placebo for pain: A systematic review with meta-analysis and Trial Sequential Analysis.
Barakji J, Korang S, Feinberg J, Maagaard M, Mathiesen O, Gluud C
PLoS One. 2023; 18(1):e0267420.
PMID: 36716312
PMC: 9886264.
DOI: 10.1371/journal.pone.0267420.
Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks.
Ang S, Sidharthan S, Lai W, Hussain N, Patel K, Gulati A
Pain Ther. 2023; 12(2):355-375.
PMID: 36639601
PMC: 10036719.
DOI: 10.1007/s40122-022-00465-y.
The Effectiveness and Safety of Medical Cannabis for Treating Cancer Related Symptoms in Oncology Patients.
Aviram J, Lewitus G, Vysotski Y, Amna M, Ouryvaev A, Procaccia S
Front Pain Res (Lausanne). 2022; 3:861037.
PMID: 35669038
PMC: 9163497.
DOI: 10.3389/fpain.2022.861037.
Cancer Initiation, Progression and Resistance: Are Phytocannabinoids from L. Promising Compounds?.
Nigro E, Formato M, Crescente G, Daniele A
Molecules. 2021; 26(9).
PMID: 34063214
PMC: 8124362.
DOI: 10.3390/molecules26092668.
Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients.
Aviram J, Lewitus G, Vysotski Y, Uribayev A, Procaccia S, Cohen I
Pharmaceuticals (Basel). 2020; 13(12).
PMID: 33265945
PMC: 7761379.
DOI: 10.3390/ph13120435.
Efficacy, tolerability and safety of cannabis-based medicines for cancer pain : A systematic review with meta-analysis of randomised controlled trials.
Hauser W, Welsch P, Klose P, Radbruch L, Fitzcharles M
Schmerz. 2019; 33(5):424-436.
PMID: 31073761
DOI: 10.1007/s00482-019-0373-3.
Systematic review and meta-analysis of cannabinoids in palliative medicine.
Mucke M, Weier M, Carter C, Copeland J, Degenhardt L, Cuhls H
J Cachexia Sarcopenia Muscle. 2018; 9(2):220-234.
PMID: 29400010
PMC: 5879974.
DOI: 10.1002/jcsm.12273.
[Cannabinoids in palliative care: Systematic review and meta-analysis of efficacy, tolerability and safety].
Mucke M, Carter C, Cuhls H, Pruss M, Radbruch L, Hauser W
Schmerz. 2016; 30(1):25-36.
PMID: 26809975
DOI: 10.1007/s00482-015-0085-2.
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence.
Jensen B, Chen J, Furnish T, Wallace M
Curr Pain Headache Rep. 2015; 19(10):50.
PMID: 26325482
DOI: 10.1007/s11916-015-0524-x.
Pharmacological options for the management of refractory cancer pain-what is the evidence?.
Afsharimani B, Kindl K, Good P, Hardy J
Support Care Cancer. 2015; 23(5):1473-81.
PMID: 25749509
DOI: 10.1007/s00520-015-2678-9.
Codeine, alone and with paracetamol (acetaminophen), for cancer pain.
Straube C, Derry S, Jackson K, Wiffen P, Bell R, Strassels S
Cochrane Database Syst Rev. 2014; (9):CD006601.
PMID: 25234029
PMC: 6513650.
DOI: 10.1002/14651858.CD006601.pub4.
Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain.
Wiffen P, Derry S, Moore R
Cochrane Database Syst Rev. 2014; (5):CD011056.
PMID: 24874470
PMC: 6483540.
DOI: 10.1002/14651858.CD011056.pub2.
The therapeutic potential of cannabis and cannabinoids.
Grotenhermen F, Muller-Vahl K
Dtsch Arztebl Int. 2012; 109(29-30):495-501.
PMID: 23008748
PMC: 3442177.
DOI: 10.3238/arztebl.2012.0495.
The endocannabinoid system and cancer: therapeutic implication.
Guindon J, Hohmann A
Br J Pharmacol. 2011; 163(7):1447-63.
PMID: 21410463
PMC: 3165955.
DOI: 10.1111/j.1476-5381.2011.01327.x.
Role of cannabinoids in the treatment of pain and (painful) spasticity.
Karst M, Wippermann S, Ahrens J
Drugs. 2010; 70(18):2409-38.
PMID: 21142261
DOI: 10.2165/11585260-000000000-00000.